Silence Therapeutics (SLN) Current Assets: 2019-2025
Historic Current Assets for Silence Therapeutics (SLN) over the last 5 years, with Sep 2025 value amounting to $133.6 million.
- Silence Therapeutics' Current Assets fell 34.70% to $133.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $133.6 million, marking a year-over-year decrease of 34.70%. This contributed to the annual value of $187.4 million for FY2024, which is 81.64% up from last year.
- Latest data reveals that Silence Therapeutics reported Current Assets of $133.6 million as of Q3 2025, which was down 10.04% from $148.6 million recorded in Q2 2025.
- Over the past 5 years, Silence Therapeutics' Current Assets peaked at $230.5 million during Q1 2024, and registered a low of $9.3 million during Q3 2021.
- Moreover, its 3-year median value for Current Assets was $148.6 million (2025), whereas its average is $156.0 million.
- In the last 5 years, Silence Therapeutics' Current Assets surged by 1,340.35% in 2022 and then crashed by 34.70% in 2025.
- Over the past 5 years, Silence Therapeutics' Current Assets (Quarterly) stood at $116.4 million in 2021, then dropped by 2.55% to $113.4 million in 2022, then fell by 9.04% to $103.2 million in 2023, then spiked by 81.64% to $187.4 million in 2024, then tumbled by 34.70% to $133.6 million in 2025.
- Its Current Assets was $133.6 million in Q3 2025, compared to $148.6 million in Q2 2025 and $169.8 million in Q1 2025.